Neil Herbert – Executive Chairman – Atlantic Lithium (ASX:A11) is an AIM, ASX, GSE and OTCQX-listed lithium company advancing its flagship project, the Ewoyaa Lithium Project, a significant lithium spodumene pegmatite discovery in Ghana, through to production to become the country’s first lithium-producing mine.
Copyright 2024 – Finance News Network
Source: Finance News Network
12 Apr 2024 - A pre-IPO interview with Cameron Woodrow, the Executive Director and CEO of Far Northern Resources Limited (ASX:FNR). Mr Woodrow discusses development of the company's three gold and base metals projects in the Northern Territory and north Queensland.
Read More06 Apr 2020 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its new drug application with the US FDA for Technegas and applications beyond pulmonary embolism in chronic chronic obstructive pulmonary ( COPD ) and asthma.
Read More17 Nov 2023 - Findi Limited (ASX:FND) Chairman Nicholas Smedley discusses the details that its Indian subsidiary TSI has successfully raised $37.6m via a placement to leading Investment group, Piramal Alternatives.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
Read More27 Aug 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly provides an update on the company, discussing collaboration with the W8banaki, listing on the Frankfurt stock exchange and the OTC Markets and outlook.
Read More15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More23 Sep 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses signs of market recovery, government support, coronavirus vaccines and small cap performance.
Read More31 Aug 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company's automation technology.
Read More
